Telomir Pharmaceuticals, Inc. Common Stock (TELO)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $36.15M
Last updated: Nov 17, 2026 at 11:04 AM ET
Telomir Pharmaceuticals, Inc. Common Stock (TELO) Competitors
The companies most similar to Telomir Pharmaceuticals, Inc. Common Stock are Plus Therapeutics (PSTV), Gain Therapeutics (GANX) and Mink Therapeutics (INKT). By market cap, Telomir Pharmaceuticals, Inc. Common Stock ranks 5th of the 13 companies on this page; Actinium Pharmaceuticals (ATNM) is the largest at $51.56M.
Peer Comparison
TELO's revenue growth of 0.0% is in line with the peer median. Like the median peer, it pays no dividend.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| Telomir Pharmaceuticals, Inc. Common Stock (TELO) | $36.15M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Plus Therapeutics Inc (PSTV) | $26.64M | N/A | 2.0x | -230.2% | -827.8% | -2.9% | 0.00% |
| Gain Therapeutics Inc (GANX) | $46.31M | N/A | N/A | 0.0% | -170.5% | -100.0% | 0.00% |
| Mink Therapeutics Inc (INKT) | $47.95M | N/A | 236.3x | 0.0% | N/A | 0.0% | 0.00% |
| Actinium Pharmaceuticals Inc (ATNM) | $51.56M | 4.1x | 1.3x | 32.2% | N/A | -100.0% | 0.00% |
| Transcode Therapeutics Inc (RNAZ) | $22.35M | N/A | N/A | 0.0% | -412.7% | 0.0% | 0.00% |
| Estrella Immunopharma Inc. (ESLA) | $22.36M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Pelthos Therapeutics Inc. (PTHS) | $29.24M | N/A | 0.5x | -199.5% | -95.4% | 0.0% | 0.00% |
| NextCure Inc (NXTC) | $29.31M | N/A | N/A | 0.0% | N/A | -100.0% | 0.00% |
| INmune Bio Inc (INMB) | $32.51M | N/A | N/A | 0.0% | N/A | 257.1% | 0.00% |
| Grace Therapeutics, Inc. (GRCE) | $38.08M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| OS Therapies Incorporated (OSTX) | $34.87M | N/A | N/A | 0.0% | 218.0% | 0.0% | 0.00% |
| Lite Strategy, Inc. (LITS) | $25.30M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Peer median | $30.91M | 4.1x | 1.7x | 0.0% | -170.5% | 0.0% | 0.00% |
Similar Companies
These are the 12 companies most similar to Telomir Pharmaceuticals, Inc. Common Stock, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.
| Company | About | Peers |
|---|---|---|
| Plus Therapeutics Inc (PSTV) | Plus Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacturing... | PSTV competitors |
| Gain Therapeutics Inc (GANX) | Gain Therapeutics, Inc., a developing biotechnology company, is dedicated to developing a variety of therapies to treat diseases caused by protein misfolding. | GANX competitors |
| Mink Therapeutics Inc (INKT) | MiNK Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of allogeneic... | INKT competitors |
| Actinium Pharmaceuticals Inc (ATNM) | Actinium Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing therapies for bone marrow transplantation... | ATNM competitors |
| Transcode Therapeutics Inc (RNAZ) | TransCode Therapeutics, Inc., a biopharmaceutical company, is dedicated to the development and commercialization of drugs for the treatment of metastatic... | RNAZ competitors |
| Estrella Immunopharma Inc. (ESLA) | Estrella Immunopharma, Inc., a preclinical-stage biopharmaceutical company, develops T-cell therapies for blood cancers and solid tumors in the United States. | ESLA competitors |
| Pelthos Therapeutics Inc. (PTHS) | Pelthos Therapeutics Inc., a bio-pharmaceutical company, develops and commercializes therapeutic products to help patients with unmet treatment burdens. | PTHS competitors |
| NextCure Inc (NXTC) | NextCure, Inc., a clinical-stage biopharmaceutical company, is dedicated to the discovery and development of novel immunomedicines to treat cancer and other... | NXTC competitors |
| INmune Bio Inc (INMB) | INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on reprogramming the patient's innate immune system to treat cancer, Alzheimer's disease... | INMB competitors |
| Grace Therapeutics, Inc. (GRCE) | Grace Therapeutics, Inc. engages in the development and commercialization of pharmaceutical products for rare and orphan diseases in Canada. | GRCE competitors |
| OS Therapies Incorporated (OSTX) | OS Therapies Incorporated is a pioneering biopharmaceutical company committed to developing innovative treatments for unmet medical needs... | OSTX competitors |
| Lite Strategy, Inc. (LITS) | Lite Strategy, Inc. a clinical-stage pharmaceutical company, focuses on the development of various therapies for the treatment of cancer. | LITS competitors |
Frequently Asked Questions About TELO
Who are Telomir Pharmaceuticals, Inc. Common Stock's main competitors?
The companies most similar to Telomir Pharmaceuticals, Inc. Common Stock include Plus Therapeutics (PSTV), Gain Therapeutics (GANX), Mink Therapeutics (INKT), Actinium Pharmaceuticals (ATNM) and Transcode Therapeutics (RNAZ), listed from the closest match.
Who is Telomir Pharmaceuticals, Inc. Common Stock's biggest competitor?
Actinium Pharmaceuticals (ATNM) is the largest of the similar companies at $51.56M; Plus Therapeutics (PSTV) is the closest match by business profile, size, sector and industry.
How does TELO stock compare with its competitors?
TELO's net margin is 0.0% against a peer median of 0.0%.
Which of Telomir Pharmaceuticals, Inc. Common Stock's competitors pays a higher dividend?
Telomir Pharmaceuticals, Inc. Common Stock pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.
Is Telomir Pharmaceuticals, Inc. Common Stock bigger than its competitors?
No. Telomir Pharmaceuticals, Inc. Common Stock is 5th by market cap among the 13 companies on this page; the largest is Actinium Pharmaceuticals (ATNM) at $51.56M.
TELO pages: Overview, Forecast, Financials, Competitors